SCD-HeFT Cost-Effectiveness Study - SCD-HeFT Cost-Effectiveness Study

Description:

SCD-HeFT was a randomized multicenter three-arm primary prevention trial of single-chamber implantable cardioverter defibrillator (ICD) therapy, amiodarone, or placebo for the treatment of patients with stable heart failure (both ischemic and nonischemic in origin). This prespecified substudy analysis examined the cost-effectiveness of these therapies.